Synthetic Lethality in Lung Cancer—From the Perspective of Cancer Genomics

Cancer is a genetic disease, and this concept is now widely exploited by both scientists and clinicians to develop new genotype-selective anticancer therapeutics. Although the quest of cancer genomics is in its dawn, recognition of the widespread applicability of genetic interactions with biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimomura, Iwao, Yamamoto, Yusuke, Ochiya, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473893/
https://www.ncbi.nlm.nih.gov/pubmed/30871030
http://dx.doi.org/10.3390/medicines6010038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473893/
https://www.ncbi.nlm.nih.gov/pubmed/30871030
http://dx.doi.org/10.3390/medicines6010038

Ejemplares similares